Radiant Skin+ IV Drip

About This IV

Radiant Skin+ is the most comprehensive collagen-targeted skin IV in the GHH catalog — engineered around the complete biochemical machinery of dermal collagen synthesis, from amino acid substrate provision through post-translational modification, crosslinking, extracellular matrix organisation, and antioxidant protection of the dermal microenvironment. The formula addresses every enzymatic step of the collagen Type I and III biosynthetic pathway (the two collagens that determine skin firmness, elasticity, and radiance) while simultaneously targeting melanin modulation, mitochondrial skin cell energetics, and epidermal barrier restoration. The collagen biosynthesis pathway begins in fibroblasts with the transcription of procollagen alpha chains — each chain is a repeating Gly-X-Y tripeptide sequence where X is frequently proline and Y is frequently hydroxyproline (4-hydroxyproline). Proline (500mg) and Lysine (100mg) are the two most critical amino acid substrates in this formula: Proline occupies the X position in the collagen tripeptide and must be present in sufficient quantity for normal procollagen chain synthesis; once incorporated, it must be hydroxylated by prolyl-4-hydroxylase (P4H) to form 4-hydroxyproline, which provides the hydrogen bonds that stabilise the collagen triple helix at body temperature. Without adequate 4-hydroxyproline content, collagen triple helices are thermally unstable and unfold at physiological temperature — producing structurally defective collagen that is rapidly degraded. Vitamin C (4000mg) is the obligate cofactor (electron donor) for P4H — it provides the reducing equivalents that maintain the enzyme's iron (Fe²⁺) cofactor in its active reduced state during the hydroxylation reaction. Fe²⁺ is oxidised to Fe³⁺ during proline hydroxylation; Vitamin C regenerates Fe²⁺ from Fe³⁺, preventing enzyme inactivation and allowing the reaction to proceed continuously. At 4000mg IV, Vitamin C achieves plasma concentrations that fully saturate P4H activity, ensuring maximum hydroxyproline incorporation into nascent collagen chains. Lysine (100mg) undergoes an identical hydroxylation reaction catalysed by lysyl hydroxylase (LH1/LH2/LH3), also Vitamin C-dependent, converting specific lysine residues to hydroxylysine. Hydroxylysine is the substrate for lysyl oxidase — the copper-dependent enzyme that deaminates hydroxylysine residues to form aldehydes (hydroxyallysine), which spontaneously condense with adjacent lysine or hydroxylysine residues to form pyridinoline and deoxypyridinoline crosslinks. These intermolecular crosslinks are the molecular basis of collagen tensile strength, elasticity, and resistance to degradation by matrix metalloproteinases (MMPs). The formula's Zinc (50mg) supports lysyl oxidase activity (zinc is required for Cu²⁺ incorporation into the enzyme during its post-translational maturation) and inhibits MMP-1 (collagenase), the primary enzyme responsible for collagen degradation in UV-damaged skin and chronic inflammation. MSM (Dimethyl Sulfone, 1000mg) is the sulfur donor for three critical roles in dermal matrix biology: (1) sulfation of glycosaminoglycans (GAGs) — chondroitin sulfate, dermatan sulfate, and heparan sulfate are the sulfated GAGs that form the hydrophilic gel-like ground substance of the dermis, retaining water between collagen and elastin fibres and maintaining the plumpness and turgor of youthful skin; without adequate sulfation, GAG chains are shorter and less hydrophilic, reducing skin water-binding capacity and turgor; (2) cysteine provision for glutathione synthesis — MSM is metabolised to cysteine, contributing to the cysteine pool available for GSH synthesis (synergistic with NAC's cysteine provision); and (3) direct inhibition of matrix metalloproteinase-1 (collagenase) and matrix metalloproteinase-3 (stromelysin) — MSM at 1000mg suppresses MMP transcription by inhibiting NF-κB and AP-1 transcription factor activation in dermal fibroblasts, preserving the existing collagen matrix while new collagen is synthesised. N-Acetylcysteine (1000mg) provides the rate-limiting cysteine substrate for glutathione (GSH) synthesis — the primary intracellular antioxidant defence in skin cells. UV radiation, infrared radiation, air pollution (PM2.5, ozone), and cigarette smoke all deplete epidermal and dermal GSH, allowing reactive oxygen species (ROS) to accumulate and activate AP-1 transcription factor, which upregulates MMP-1 expression and simultaneously suppresses type I procollagen synthesis. The result is a double insult to skin collagen: increased degradation + decreased synthesis. NAC (1000mg IV) rapidly restores GSH pools in both epidermal keratinocytes and dermal fibroblasts, reversing the oxidative signalling that drives this double insult. NAC also activates Nrf2 transcription factor, inducing endogenous antioxidant enzyme expression (HO-1, NQO1, catalase) for 48–72 hours post-infusion — providing sustained photoprotection extending well beyond the infusion window. Niacinamide B3 (200mg) — at this IV dose far exceeding topical delivery limits — targets three distinct skin mechanisms simultaneously: (1) SIRT1-mediated DNA repair activation in UV-damaged keratinocytes and fibroblasts (via NAD⁺ restoration) — reducing the p53-dependent apoptosis that thins the epidermis and depletes the proliferative basal layer; (2) ceramide synthesis stimulation — niacinamide upregulates serine palmitoyltransferase and ceramide synthase expression in keratinocytes, increasing epidermal ceramide content and TEWL (transepidermal water loss) reduction, enhancing barrier function and skin moisture retention; and (3) melanosome transfer inhibition via PAR2 suppression — reducing visible hyperpigmentation that dulls skin radiance without affecting melanocyte viability. L-Carnitine (500mg) optimises mitochondrial energy production in fibroblasts and keratinocytes — skin cells have high energy demands for procollagen synthesis (each collagen molecule requires 1400+ peptide bonds, each requiring ATP), cell division, and active ion transport for barrier maintenance. L-Carnitine enables efficient fatty acid oxidation (beta-oxidation) for ATP production, reducing the reliance on glycolytic energy generation that produces lactate and acidifies the dermal microenvironment (lactic acidosis in skin impairs collagen synthesis and promotes MMP activation). Dexpanthenol B5 (200mg) is converted to pantothenate and Coenzyme A, supporting the Krebs cycle energy flux in fibroblasts and serving as a direct wound-healing promoter via its effect on fibroblast proliferation and migration — B5 specifically upregulates TGF-β1 receptor expression in fibroblasts, enhancing their sensitivity to the primary growth factor driving collagen synthesis. Selenium (0.2mg) activates selenoprotein P and thioredoxin reductase in dermal fibroblasts, providing mitochondrial antioxidant protection and supporting the 15-kDa selenoprotein that specifically protects skin cells against UV-induced ferroptosis (iron-dependent lipid peroxidation cell death that contributes to dermal fibroblast depletion in photoaged skin). Magnesium Chloride (500mg) is required for ATP-Mg²⁺ complex formation in all ATP-utilising steps of procollagen synthesis, and activates the calcineurin/NFAT signalling pathway in fibroblasts that promotes collagen gene transcription. Pyridoxine B6 (100mg) supports collagen crosslinking by activating transaminases that regenerate the amino acid substrates, and Riboflavin B2 (5mg) provides FAD for complex II of the mitochondrial ETC in fibroblasts — completing the full mitochondrial B-vitamin cofactor profile needed for maximum ATP production per fatty acid molecule oxidised. L-Glutamine (500mg) is the primary nitrogen donor for the biosynthesis of non-essential amino acids in fibroblasts under conditions of high collagen synthetic demand, and supports gut barrier integrity to prevent systemic LPS-driven inflammation that activates fibroblast MMP-1 expression.